Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
The medical device reprocessing market is projected to reach USD 3.9 billion by 2027 from USD 2.0 billion in 2022, at a CAGR of 13.7% during the forecast period. Growth in the market is mainly driven by the growing need to minimize hospital costs and the rising geriatric population, and the favourable regulatory approvals for reuse of single-use reprocessed medical devices. However, the requirement to follow stringent regulatory procedures to enter the medical device reprocessing market may pose a threat to the market growth.
Based on type, the reprocessing support & services segment holds the largest market share in 2021
Based on type, the medical device reprocessing market is segmented into reprocessing support & services and reprocessed medical devices. In 2021, the reprocessing support & services segment accounted for the largest share of this market, primarily due to the growing need implement strategies to reduce medical wastes.
Based on device type , critical devices segment accounted for the largest share of the medical device reprocessing market
Based on the device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The growth of this segment is mainly attributed to the increased utilization of reprocessed medical devices for cardiac surgeries and electrophysiology procedures.
Based on application, cardiology segment is expected to have the highest CAGR during the forecast period
Based on application, the medical device reprocessing market is segmented into cardiology, gastroenterology, gynecology, arthroscopy and orthopedic surgery, general surgery & anesthesia, and other applications (urology, non-invasive surgeries, and patient monitoring). The cardiology segment is expected to register the highest growth during the forecast period. This can be attributed to the increasing prevalence of cardiovascular diseases as well as the increasing number of cardiac procedures, which utilizes a large volume of reprocessed cardiology catheters and other equipments.
North America accounted for the largest share of the medical device reprocessing market in 2021
North America accounted for the largest share of the medical device reprocessing market in 2021. Factors such as the increasing need to reduce the healthcare costs in US, and the presence of top medical device reprocessing service providers in the US region are expected to contribute to the growth of the medical device reprocessing market in North America.
Break of primary participants was as mentioned below:
The key players operating in the medical device reprocessing market include Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US), SureTek Medical (US), Konoike Group (Japan), Avante Health Solutions (US), Medsalv (New Zealand), and Vitruvia Medical AG (Switzerland).
Research Coverage:
The report analyzes the medical device reprocessing market aims at estimating the market size and future growth potential of this market based on various segments such as type, device type, application, and region. The report also includes a service portfolio matrix of various medical device reprocessing services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Based on type, the reprocessing support & services segment holds the largest market share in 2021
Based on type, the medical device reprocessing market is segmented into reprocessing support & services and reprocessed medical devices. In 2021, the reprocessing support & services segment accounted for the largest share of this market, primarily due to the growing need implement strategies to reduce medical wastes.
Based on device type , critical devices segment accounted for the largest share of the medical device reprocessing market
Based on the device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The growth of this segment is mainly attributed to the increased utilization of reprocessed medical devices for cardiac surgeries and electrophysiology procedures.
Based on application, cardiology segment is expected to have the highest CAGR during the forecast period
Based on application, the medical device reprocessing market is segmented into cardiology, gastroenterology, gynecology, arthroscopy and orthopedic surgery, general surgery & anesthesia, and other applications (urology, non-invasive surgeries, and patient monitoring). The cardiology segment is expected to register the highest growth during the forecast period. This can be attributed to the increasing prevalence of cardiovascular diseases as well as the increasing number of cardiac procedures, which utilizes a large volume of reprocessed cardiology catheters and other equipments.
North America accounted for the largest share of the medical device reprocessing market in 2021
North America accounted for the largest share of the medical device reprocessing market in 2021. Factors such as the increasing need to reduce the healthcare costs in US, and the presence of top medical device reprocessing service providers in the US region are expected to contribute to the growth of the medical device reprocessing market in North America.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
The key players operating in the medical device reprocessing market include Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US), SureTek Medical (US), Konoike Group (Japan), Avante Health Solutions (US), Medsalv (New Zealand), and Vitruvia Medical AG (Switzerland).
Research Coverage:
The report analyzes the medical device reprocessing market aims at estimating the market size and future growth potential of this market based on various segments such as type, device type, application, and region. The report also includes a service portfolio matrix of various medical device reprocessing services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on service portfolios offered by the top players in the global medical device reprocessing market. The report analyzes this market by type, device type, and application.
- Service Enhancement/FDA Approvals: Detailed insights on upcoming trends and service approvals in the global medical device reprocessing market
- Market Development: Comprehensive information on the lucrative emerging markets by type, device type, and application.
- Market Diversification: Exhaustive information about new services, growing geographies, recent developments, and investments in the global medical device reprocessing market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global medical device reprocessing market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS
2.4 DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET
3 EXECUTIVE SUMMARY
FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET
4 PREMIUM INSIGHTS
4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET
FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE
HEALTHCARE COSTS TO DRIVE MARKET
4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021)
FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020–2027)
FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing level of supply chain cost savings in healthcare facilities
5.2.1.2 Growing adoption of strategies for sustainability and
environmental safety
TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING
5.2.1.3 Rising geriatric population
FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS
5.2.2 RESTRAINTS
5.2.2.1 Increasing risk of hospital-acquired infections among patients
5.2.2.2 Increasing number of medical device surface alterations
due to reprocessing
TABLE 5 IMPACT ANALYSIS: RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.3.1 Regulatory changes favoring adoption of medical device reprocessing
5.2.3.2 Growing opportunities and favorable regulations in
developing countries
TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory procedures for reprocessed medical devices
TABLE 7 IMPACT ANALYSIS: CHALLENGES
5.3 KEY CONFERENCES AND EVENTS
TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED
LIST OF CONFERENCES AND EVENTS
5.4 INDUSTRY TRENDS
5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH
THROUGH ACQUISITIONS
TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET
5.4.2 SPECIALTY REPROCESSING
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT FROM NEW ENTRANTS
5.5.2 THREAT FROM SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
5.7.1.2 Canada
5.7.2 EUROPE
TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING
5.7.3 ASIA PACIFIC
5.7.3.1 Japan
5.7.3.2 Australia
5.7.3.3 Rest of Asia Pacific
TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING
5.8 TECHNOLOGY ANALYSIS
TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE
REPROCESSING MARKET
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET
5.10 ECOSYSTEM ANALYSIS
FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING
FIGURE 26 PATENT PUBLICATION TRENDS (2011–JULY 2022)
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011–JULY 2022)
FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011–JULY 2022)
TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021–2022
5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET
6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 REPROCESSING SUPPORT AND SERVICES
6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET
TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 REPROCESSED MEDICAL DEVICES
6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER
COSTS TO DRIVE MARKET
TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS
TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE
7.1 INTRODUCTION
TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
7.2 CRITICAL DEVICES
7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET
TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY
TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SEMI-CRITICAL DEVICES
7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 NON-CRITICAL DEVICES
7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET
TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 CARDIOLOGY
8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET
TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 GASTROENTEROLOGY
8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS
TO DRIVE MARKET
TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY
8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET
TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING
TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 GYNECOLOGY
8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET
TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.6 GENERAL SURGERY
8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET
TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021)
TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Presence of major players and healthcare cost reduction strategies to drive market
FIGURE 31 US: TOTAL NUMBER OF HOSPITALS
TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing geriatric population and increasing chronic diseases
to drive market
TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Government initiatives and well-established standards to
drive market
TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing hospital admissions to drive market
TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Growing diagnostic medical device market with rising chronic diseases to propel market
TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing use of diagnostic devices and government initiatives to drive market
TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing focus on reducing hospital costs to drive market
TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.1 AUSTRALIA
9.4.1.1 Growing adoption of medical devices for diagnosis and treatment to drive market
TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Regulatory reforms and need to reduce hospital costs to drive market
TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Government initiatives and developing economy to drive market
TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Government initiatives for diagnosis and treatment to drive market
TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE
2020–2027 (USD MILLION)
TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET
TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET
TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL
DEVICE REPROCESSING MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE
REPROCESSING MARKET
10.4 MARKET SHARE ANALYSIS, 2021
FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021
TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE BENCHMARKING
TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS
10.6 COMPANY FOOTPRINT
TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET
TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES)
TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES)
TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES)
10.7 COMPANY EVALUATION QUADRANT
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE PLAYERS
10.7.4 PARTICIPANTS
FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021)
10.8 COMPETITIVE SCENARIO
10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS
10.8.2 DEALS
10.8.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER CORPORATION
TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021)
11.1.2 JOHNSON & JOHNSON
TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW
FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
11.1.3 MEDTRONIC PLC
TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.4 STERIS HEALTHCARE
TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW
FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021)
11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES)
TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.6 ARJO GROUP (RENU MEDICAL, INC.)
TABLE 105 ARJO GROUP: COMPANY OVERVIEW
FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021)
11.1.7 VANGUARD AG
TABLE 106 VANGUARD AG: COMPANY OVERVIEW
11.1.8 MEDLINE RENEWAL
TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW
11.1.9 INNOVATIVE HEALTH
TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW
11.1.10 STERIPRO CANADA, INC
TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW
11.1.11 NORTHEAST SCIENTIFIC, INC.
TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 SURETEK MEDICAL
11.2.2 KONOIKE GROUP
11.2.3 AVANTE HEALTH SOLUTIONS
11.2.4 MEDSALV
11.2.5 VITRUVIA MEDICAL AG
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS
2.4 DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET
3 EXECUTIVE SUMMARY
FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET
4 PREMIUM INSIGHTS
4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET
FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE
HEALTHCARE COSTS TO DRIVE MARKET
4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021)
FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020–2027)
FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing level of supply chain cost savings in healthcare facilities
5.2.1.2 Growing adoption of strategies for sustainability and
environmental safety
TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING
5.2.1.3 Rising geriatric population
FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS
5.2.2 RESTRAINTS
5.2.2.1 Increasing risk of hospital-acquired infections among patients
5.2.2.2 Increasing number of medical device surface alterations
due to reprocessing
TABLE 5 IMPACT ANALYSIS: RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.3.1 Regulatory changes favoring adoption of medical device reprocessing
5.2.3.2 Growing opportunities and favorable regulations in
developing countries
TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory procedures for reprocessed medical devices
TABLE 7 IMPACT ANALYSIS: CHALLENGES
5.3 KEY CONFERENCES AND EVENTS
TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED
LIST OF CONFERENCES AND EVENTS
5.4 INDUSTRY TRENDS
5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH
THROUGH ACQUISITIONS
TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET
5.4.2 SPECIALTY REPROCESSING
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT FROM NEW ENTRANTS
5.5.2 THREAT FROM SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
5.7.1.2 Canada
5.7.2 EUROPE
TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING
5.7.3 ASIA PACIFIC
5.7.3.1 Japan
5.7.3.2 Australia
5.7.3.3 Rest of Asia Pacific
TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING
5.8 TECHNOLOGY ANALYSIS
TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE
REPROCESSING MARKET
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET
5.10 ECOSYSTEM ANALYSIS
FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING
FIGURE 26 PATENT PUBLICATION TRENDS (2011–JULY 2022)
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011–JULY 2022)
FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011–JULY 2022)
TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021–2022
5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET
6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 REPROCESSING SUPPORT AND SERVICES
6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET
TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 REPROCESSED MEDICAL DEVICES
6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER
COSTS TO DRIVE MARKET
TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS
TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE
7.1 INTRODUCTION
TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
7.2 CRITICAL DEVICES
7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET
TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY
TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SEMI-CRITICAL DEVICES
7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 NON-CRITICAL DEVICES
7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET
TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 CARDIOLOGY
8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET
TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 GASTROENTEROLOGY
8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS
TO DRIVE MARKET
TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY
8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET
TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING
TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 GYNECOLOGY
8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET
TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.6 GENERAL SURGERY
8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET
TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021)
TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Presence of major players and healthcare cost reduction strategies to drive market
FIGURE 31 US: TOTAL NUMBER OF HOSPITALS
TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing geriatric population and increasing chronic diseases
to drive market
TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Government initiatives and well-established standards to
drive market
TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing hospital admissions to drive market
TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Growing diagnostic medical device market with rising chronic diseases to propel market
TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing use of diagnostic devices and government initiatives to drive market
TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing focus on reducing hospital costs to drive market
TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.1 AUSTRALIA
9.4.1.1 Growing adoption of medical devices for diagnosis and treatment to drive market
TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Regulatory reforms and need to reduce hospital costs to drive market
TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Government initiatives and developing economy to drive market
TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Government initiatives for diagnosis and treatment to drive market
TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE
2020–2027 (USD MILLION)
TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET
TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET
TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL
DEVICE REPROCESSING MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE
REPROCESSING MARKET
10.4 MARKET SHARE ANALYSIS, 2021
FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021
TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE BENCHMARKING
TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS
10.6 COMPANY FOOTPRINT
TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET
TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES)
TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES)
TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES)
10.7 COMPANY EVALUATION QUADRANT
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE PLAYERS
10.7.4 PARTICIPANTS
FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021)
10.8 COMPETITIVE SCENARIO
10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS
10.8.2 DEALS
10.8.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER CORPORATION
TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021)
11.1.2 JOHNSON & JOHNSON
TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW
FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
11.1.3 MEDTRONIC PLC
TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.4 STERIS HEALTHCARE
TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW
FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021)
11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES)
TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.6 ARJO GROUP (RENU MEDICAL, INC.)
TABLE 105 ARJO GROUP: COMPANY OVERVIEW
FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021)
11.1.7 VANGUARD AG
TABLE 106 VANGUARD AG: COMPANY OVERVIEW
11.1.8 MEDLINE RENEWAL
TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW
11.1.9 INNOVATIVE HEALTH
TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW
11.1.10 STERIPRO CANADA, INC
TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW
11.1.11 NORTHEAST SCIENTIFIC, INC.
TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 SURETEK MEDICAL
11.2.2 KONOIKE GROUP
11.2.3 AVANTE HEALTH SOLUTIONS
11.2.4 MEDSALV
11.2.5 VITRUVIA MEDICAL AG
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
